Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 72151 - 72175 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	PER2	8864	downregulated	Silicon Dioxide analog results in decreased expression of PER2 mRNA	2q37.3	A24195
Silicon dioxide	Approved	PER3	8863	upregulated	Silicon Dioxide analog results in increased expression of PER3 mRNA	1p36.23	A24195
Silicon dioxide	Approved	PERM1	84808	downregulated	Silicon Dioxide analog results in decreased expression of PERM1 mRNA	1p36.33	A24195
Silicon dioxide	Approved	PEX1	5189	downregulated	Silicon Dioxide results in decreased expression of PEX1 mRNA	7q21.2	A24196
Silicon dioxide	Approved	PEX11G	92960	downregulated	Silicon Dioxide analog results in decreased expression of PEX11G mRNA	19p13.2	A24195
Silicon dioxide	Approved	PEX16	9409	upregulated	Silicon Dioxide analog results in increased expression of PEX16 mRNA	11p11.2	A24194
Silicon dioxide	Approved	PF4	5196	downregulated	Silicon Dioxide analog results in decreased expression of PF4 mRNA	4q13.3	A24195
Silicon dioxide	Approved	PFAS	5198	upregulated	Silicon Dioxide analog results in increased expression of PFAS mRNA	17p13.1	A24195
Silicon dioxide	Approved	PFDN2	5202	upregulated	Silicon Dioxide analog results in increased expression of PFDN2 mRNA	1q23.3	A24195
Silicon dioxide	Approved	PFKFB2	5208	upregulated	Silicon Dioxide analog results in increased expression of PFKFB2 mRNA	1q32.1	A24195
Silicon dioxide	Approved	PFKFB3	5209	downregulated	Silicon Dioxide analog results in decreased expression of PFKFB3 mRNA	10p15.1	A24194
Silicon dioxide	Approved	PFKFB3	5209	upregulated	Silicon Dioxide analog results in increased expression of PFKFB3 mRNA	10p15.1	A24195
Silicon dioxide	Approved	PFKL	5211	downregulated	Silicon Dioxide analog results in decreased expression of PFKL mRNA	21q22.3	A24195
Silicon dioxide	Approved	PFKP	5214	upregulated	Silicon Dioxide analog results in increased expression of PFKP mRNA	10p15.2	A24195
Silicon dioxide	Approved	PFN3	345456	downregulated	Silicon Dioxide analog results in decreased expression of PFN3 mRNA	5q35.3	A24195
Silicon dioxide	Approved	PGAM5	192111	upregulated	Silicon Dioxide analog results in increased expression of PGAM5 mRNA	12q24.33	A24195
Silicon dioxide	Approved	PGAP2	27315	downregulated	Silicon Dioxide results in decreased expression of PGAP2 mRNA	11p15.4	A24196
Silicon dioxide	Approved	PGD	5226	downregulated	Silicon Dioxide analog results in decreased expression of PGD mRNA	1p36.22	A24195
Silicon dioxide	Approved	PGK1	5230	downregulated	Silicon Dioxide analog results in decreased expression of PGK1 mRNA	Xq21.1	A24195
Silicon dioxide	Approved	PGM5	5239	downregulated	Silicon Dioxide analog results in decreased expression of PGM5 mRNA	9q21.11	A24195
Silicon dioxide	Approved	PGM5-AS1	572558	upregulated	Silicon Dioxide analog results in increased expression of PGM5-AS1 mRNA	9q21.11	A24195
Silicon dioxide	Approved	PGPEP1	54858	downregulated	Silicon Dioxide results in decreased expression of PGPEP1 mRNA	19p13.11	A24196
Silicon dioxide	Approved	PGPEP1L	145814	upregulated	Silicon Dioxide analog results in increased expression of PGPEP1L mRNA	15q26.3	A24195
Silicon dioxide	Approved	PHACTR1	221692	downregulated	Silicon Dioxide analog results in decreased expression of PHACTR1 mRNA	6p24.1	A24194
Silicon dioxide	Approved	PHEX	5251	downregulated	Silicon Dioxide analog results in decreased expression of PHEX mRNA	Xp22.11	A24195

Displaying entries 72151 - 72175 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability